Jupiter Neurosciences shareholders approve 4x increase in authorized shares to 500M and new equity plan

JUPITER NEUROSCIENCES, INC.

Authorized common stock increased from 125M to 500M shares via amendment approved by 20.2M votes for, 4.5M against.
2025 Equity Incentive Plan approved, authorizing 5,250,000 shares for future equity awards.
Potential issuance of up to $20M of stock to Yorkville under SEPA (including convertible notes) approved with 20.1M for, 24.7K against.
Seven director nominees elected; Christer Rosén, Marshall Hayward, Alison Silva, Nicholas Hemmerly, Julie Kampf, Allison Brady, Holger Weis.
Cherry Bekaert ratified as independent auditor for FY2025 with 24.6M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.